Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Catalent | Contract Pharma

What are you searching for?

Sign in

Financial Report: Catalent

Clinical Services up 22% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Catalent
 
2Q Revenues: $454.9 million (flat)

2Q Earnings: $30.6 million (-33%)

YTD Revenues: $877.9 million (flat)

YTD Earnings: $39.5 million (+51%)

Comments: Revenue from the Oral Technologies segment was $255.1 million in the quarter, down 8%, attributable to the temporary suspension of operations of the Beinheim facility, lower demand for certain modified release technologies, partially offset by increased demand for certain softgel products. Revenue from the Development and Clinical Services segment was $131.6 million, up 22% driven by analytical services, the timing of resolution of volume commitments and increased sales volumes for integrated oral solids development and manufacturing, as well as growth in clinical services and the impact of the Micron acquisition. Revenue from the Medication Delivery Solutions segment was $71.1 million, down 4%, with increased demand for the blow-fill-seal technology platform, partially offset by the timing of resolution of volume commitments and decreased demand for injectable products at the company’s European pre-filled syringe operations.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics